Samrat Pharmachem

378.50
-15.55
(-3.95%)
Market Cap
116.99 Cr
EPS
7.00
PE Ratio
13.67
Dividend Yield
0.25 %
Industry
Healthcare
52 Week High
646.00
52 Week Low
302.05
PB Ratio
1.75
Debt to Equity
0.21
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.13
36.71
#1 49,887.20
12.06
#1 9,648
13.77
62.28
6,082.00
1,61,457.99
79.83
8,184.00
0.89
1,600
#1 64.53
65.97
1,530.00
1,23,565.09
25.11
26,520.70
14.17
4,155
47.38
63.02
3,235.00
1,09,487.10
60.42
10,785.70
11.59
1,656
13.54
62.35
2,552.90
1,05,327.17
52.60
10,615.60
19.57
1,942
-16.38
64.60
1,173.10
97,889.96
#1 18.66
28,905.40
12.36
5,578
1.69
61.75
2,038.30
93,056.74
33.50
20,141.50
#1 19.94
1,936
38.82
57.87
864.90
87,029.18
19.53
19,831.50
13.82
3,831
29.92
51.06
1,226.70
71,246.94
20.72
29,559.20
17.55
3,169
-10.04
65.79
29,800.00
63,322.92
47.82
6,097.20
10.80
1,201
16.01
49.09
Growth Rate
Revenue Growth
-9.03 %
Net Income Growth
-86.75 %
Cash Flow Change
199.68 %
ROE
-87.36 %
ROCE
-86.90 %
EBITDA Margin (Avg.)
-82.65 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
48
62
71
93
112
138
180
222
311
283
299
Expenses
46
61
67
87
108
131
170
198
287
279
286
EBITDA
2
1
4
6
4
7
9
25
24
4
13
Operating Profit %
2 %
2 %
5 %
6 %
3 %
5 %
5 %
11 %
8 %
1 %
4 %
Depreciation
0
0
0
0
0
0
1
1
1
1
1
Interest
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
1
0
3
5
2
6
7
24
23
3
12
Tax
0
0
1
2
1
2
2
6
6
0
3
Net Profit
0
0
2
3
2
4
5
17
17
2
9
EPS in ₹
1.02
0.97
5.68
10.41
4.97
13.71
17.26
55.62
53.83
7.00
28.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
26
36
36
41
40
58
57
85
117
122
Fixed Assets
7
7
7
7
7
7
9
10
11
11
Current Assets
19
28
28
33
33
50
47
71
99
103
Capital Work in Progress
0
0
0
0
0
1
0
0
0
0
Investments
0
2
0
0
0
0
0
0
2
3
Other Assets
19
27
29
34
33
50
48
75
104
108
Total Liabilities
26
36
36
41
40
58
57
85
117
122
Current Liabilities
12
21
19
21
19
34
27
37
53
56
Non Current Liabilities
1
2
2
1
1
0
0
1
0
0
Total Equity
14
14
15
19
20
24
30
47
63
65
Reserve & Surplus
10
11
12
15
17
21
27
44
60
62
Share Capital
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
-1
-1
1
-1
0
15
-3
-2
Investing Activities
0
-2
1
-2
2
-2
-3
-1
-3
-0
Operating Activities
-1
-0
-3
0
2
-1
5
18
-9
9
Financing Activities
0
2
1
2
-4
2
-2
-2
10
-11

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
49.30 %
49.30 %
49.30 %
49.65 %
49.65 %
49.65 %
49.54 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.95 %
49.09 %
49.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.24 %
3.24 %
3.24 %
3.24 %
3.24 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.22 %
0.22 %
0.22 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
42.44 %
42.93 %
42.96 %
41.06 %
37.41 %
36.70 %
37.09 %
37.89 %
38.48 %
38.81 %
42.58 %
42.61 %
41.69 %
40.79 %
41.34 %
41.95 %
41.58 %
Others
8.26 %
7.77 %
7.74 %
9.29 %
12.95 %
13.65 %
13.37 %
13.47 %
12.88 %
12.55 %
8.78 %
8.75 %
6.22 %
7.11 %
6.25 %
5.72 %
6.09 %
No of Share Holders
2,885
5,189
5,214
4,846
4,675
4,768
7,390
8,040
8,039
7,938
8,445
8,065
7,478
7,169
6,984
6,844
6,785

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.3 0.32 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financial Year Ended March 31 2025Mar 26, 2025
Closure of Trading WindowMar 20, 2025
Integrated Filing (Financial)Mar 04, 2025
General Announcement-Outcome Of Board Meeting (14-02-2025)Feb 14, 2025
Outcome Of The Board Meeting Held Today - 14-02-2024Feb 14, 2025
Approval Of Un-Audited Financial Results For The Quarter Ended December 31 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayFeb 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 13, 2025
Closure of Trading WindowDec 31, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2024Dec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2024
Un-Audited Financial Results For The Quarter Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 18, 2024
Closure of Trading WindowSep 27, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Sep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2024
Book ClosureSep 04, 2024
Record Date: Thursday, September 19, 2024Sep 04, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
32Nd Annual General Meeting On Thursday, September 26, 2024Sep 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2024
Un-Audited Financial Results For The Quarter Ended June 30, 2024Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayAug 13, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 18, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 04, 2024
Closure of Trading WindowJun 29, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended June 30, 2024Jun 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2024
Audited Financial Results For The Year Ended March 31, 2024May 30, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayMay 30, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMApr 29, 2024
Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Year Ended March 31, 2024Apr 18, 2024
Compliance Certificate Under Regulation 7(3) For The Period: 01St April 2023 To 31St March, 2024Apr 10, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportApr 10, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 10, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 08, 2024
Board Meeting Intimation for Notice Of Board Meeting For Audited Financial Results For The Year Ended March 31, 2024Mar 28, 2024
Closure of Trading WindowMar 28, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 05, 2024
Announcement under Regulation 30 (LODR)-Credit RatingFeb 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 21, 2024
Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results For The Quarter Ended December 31, 2023Feb 14, 2024

Technical Indicators

RSI(14)
Neutral
66.35
ATR(14)
Volatile
22.99
STOCH(9,6)
Neutral
76.12
STOCH RSI(14)
Overbought
91.88
MACD(12,26)
Bullish
9.83
ADX(14)
Weak Trend
22.37
UO(9)
Bearish
54.22
ROC(12)
Uptrend And Accelerating
13.36
WillR(14)
Neutral
-25.17